CN110229773B - Method for collecting and preserving wet cells of genetically engineered bacteria - Google Patents

Method for collecting and preserving wet cells of genetically engineered bacteria Download PDF

Info

Publication number
CN110229773B
CN110229773B CN201910486085.1A CN201910486085A CN110229773B CN 110229773 B CN110229773 B CN 110229773B CN 201910486085 A CN201910486085 A CN 201910486085A CN 110229773 B CN110229773 B CN 110229773B
Authority
CN
China
Prior art keywords
ala
leu
gly
val
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910486085.1A
Other languages
Chinese (zh)
Other versions
CN110229773A (en
Inventor
张君轩
付妍
付雪蓉
解雨晨
任泓宇
刘立明
刘佳
陈修来
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201910486085.1A priority Critical patent/CN110229773B/en
Publication of CN110229773A publication Critical patent/CN110229773A/en
Application granted granted Critical
Publication of CN110229773B publication Critical patent/CN110229773B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/05Oxidoreductases acting on the CH-OH group of donors (1.1) with a quinone or similar compound as acceptor (1.1.5)
    • C12Y101/05006Formate dehydrogenase-N (1.1.5.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y104/00Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/01Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
    • C12Y104/01009Leucine dehydrogenase (1.4.1.9)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01019Threonine ammonia-lyase (4.3.1.19)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a method for collecting and storing wet cells of genetically engineered bacteria, belonging to the technical field of biological engineering. The method is used for collecting and storing wet cells of escherichia coli which co-expresses threonine deaminase, formate dehydrogenase and leucine dehydrogenase, the thawed wet cells are converted to produce L-2-aminobutyric acid after the wet cells are stored for 2 months, the conversion rate of a substrate L-threonine reaches 96.8%, and the enzyme activities of the three enzymes relative to fresh wet cells can reach more than 90.0%.

Description

Method for collecting and preserving wet cells of genetically engineered bacteria
Technical Field
The invention relates to a method for collecting and storing wet cells of a genetic engineering bacterium, belonging to the technical field of biological engineering.
Background
L-2-aminobutyric acid (L-ABA) is an unnatural amino acid, is used as an important chemical raw material and a chiral medical intermediate, and is widely applied to the field of synthesis of antibacterial and antitubercular drugs of ethambutol hydrochloride, novel antiepileptic drugs of levetiracetam, brivaracetam and the like.
At present, reported methods for synthesizing L-ABA include chemical methods and biological methods. The chemical methods mainly comprise a ketobutyric acid reduction method, a desulfurization reaction method and the like, the chemical methods are easy to form racemes, are not beneficial to the synthesis of chiral compounds, have severe reaction conditions, high reagent cost and serious environmental pollution, and are not easy to carry out industrial production.
The biological method is widely concerned due to the characteristics of mild reaction conditions, high stereoselectivity, green environmental protection and the like. The enzyme method mainly utilizes threonine deaminase (L-TD), Leucine Dehydrogenase (LDH), coupled Formate Dehydrogenase (FDH) or Glucose Dehydrogenase (GDH), synthesizes L-ABA by taking L-threonine as a substrate, and simultaneously realizes the circulation of coenzyme NADH by FDH or GDH. The work of producing L-ABA by using amino acid dehydrogenase conversion was earlier carried out abroad. In 1997 Galkin et al used 2-ketobutyrate as a substrate, L-ABA of 36g/L was finally obtained by coupling Leucine Dehydrogenase (LDH) derived from T.intermedia and Formate Dehydrogenase (FDH) which is an NADH recycling enzyme, and the product yield was 88%, but the substrate 2-ketobutyrate was unstable and high in price. Tao et al expressed L-TD, LDH and FDH in E.coli respectively in 2014, and converted 30mol of L-threonine into 29.2mol of L-ABA in a 30L conversion system, the yield was 97.3%, and the space-time yield reached 6.37 g/(L.h). Zhang Caij in 2018 constructs two recombinant escherichia coli which respectively express TD and co-express LDH/GDH, on the basis, a whole-cell transformation system which takes L-threonine and D-glucose as substrates and coproduces L-ABA and D-gluconic acid is constructed, a fed-batch strategy is adopted, and the L-ABA at 141.6g/L and the D-gluconic acid at 269.4g/L are finally transformed, so that the transformation effect of the method is good, but two thalli and two substrates need to be added, the two products are separated, and the complexity of the process is increased.
The inventor previously uses the recombinant strain of double plasmids to co-express L-TD, LDH and FDH, realizes the production of L-ABA (patent publication No.: CN109266595A) by adding single strain and transforming L-threonine by whole cells, and simplifies the production process. In the practical application process, the bacterial sludge collected by fermentation needs to be preserved and then is unfrozen for a conversion experiment, and the enzyme activity is influenced by the collection and storage modes, so that the conversion effect is influenced. At lower temperatures, for example, FDH is deactivated by oxidation of the free thiol groups. Therefore, the method for collecting and preserving the whole cells, which has the advantages of high efficiency, low cost, easy amplification and capability of reducing enzyme activity loss in the preservation process, is provided, and has important application value for realizing the enzyme method industrial production.
Disclosure of Invention
The invention aims to provide a method for collecting and preserving wet cells of a genetic engineering strain, which comprises the steps of cooling fermentation liquor of the genetic engineering strain to 4-15 ℃, adding 50-100 mmol/L cysteine and/or 5-20 mu mol/L coenzyme pyridoxal phosphate, uniformly mixing, and centrifuging at 6000-8000 rpm for 5-10 min to obtain wet cells; the genetic engineering strain takes escherichia coli as a host to co-express threonine deaminase, formate dehydrogenase and leucine dehydrogenase.
In one embodiment of the present invention, the centrifugation temperature is 4 to 15 ℃.
In one embodiment of the invention, the moisture content of the collected wet cell bacterial sludge is 75% to 80%.
In one embodiment of the invention, the engineered strain is stored frozen at-10 to-20 ℃.
In one embodiment of the invention, the genetically engineered strain is stored in batches and is not subjected to repeated freeze thawing.
In one embodiment of the invention, when the engineering strain is used for a transformation experiment, 3.5-4.5 times of deionized water with the volume of 15-25 ℃ is added, and the engineering strain is naturally thawed or is stirred and thawed at a low speed of 25-50 rpm.
In one embodiment of the invention, the threonine deaminase is derived from Escherichia coli W3110, and has a gene sequence shown in SEQ ID NO.1 and an amino acid sequence shown in SEQ ID NO. 4.
In one embodiment of the invention, the leucine dehydrogenase is derived from Bacillus thuringiensis serovar kurstaki YBT-1520, the gene sequence is shown as SEQ ID NO.2, and the amino acid sequence is shown as SEQ ID NO. 5.
In one embodiment of the present invention, the formate dehydrogenase is derived from Candida, and has a gene sequence shown in SEQ ID NO.3 and an amino acid sequence shown in SEQ ID NO. 6.
In one embodiment of the invention, the pETDuet-1 plasmid is used to express threonine deaminase, formate dehydrogenase and the pRSFDuet-1 plasmid is used to express leucine dehydrogenase.
In one embodiment of the present invention, the escherichia coli is escherichia coli BL 21.
The invention also aims to provide the application of the method in producing the L-2-aminobutyric acid, wherein the L-threonine is used as a substrate, and wet cells of the genetic engineering strain are used as a whole-cell catalyst.
In one embodiment of the invention, the conversion conditions are: in a 5L fermentation tank, stirring at 400r/min and 37 deg.C, aerating at 3vvm, dissolving L-threonine in purified water at 80g/L, ammonium formate at 40g/L, and NAD+30mg/L of wet cells, 20g/L of wet cells, pH 8.0 controlled with 4mol/L NaOH solution, and conversion volume 2L.
The invention has the beneficial effects that:
(1) according to the method, the treatment processes of freeze drying, addition of a large amount of protective agents and the like are not needed, only 50-100 mmol/L cysteine and 5-20 mu mol/L coenzyme pyridoxal phosphate (PLP) are added into the fermentation liquor after the fermentation liquor is cooled, and then the thalli are collected through low-temperature centrifugation, so that the cost is low, and the operation is simple and convenient.
(2) After the thalli are collected according to the method, the thalli are stored in a refrigeration house at the temperature of-10 to-20 ℃ for 2 months, the enzyme activity is maintained above 90 percent, the conversion rate can still reach 96.8 percent, and the method has industrial application value.
Drawings
FIG. 1: influence of the addition of the protective agent on the activity of the FDH preserved enzyme (a) an L-TD enzyme activity change curve; (b) LDH enzyme activity change curve; (c) FDH enzyme activity change curve
FIG. 2: production of L-2-aminobutyric acid by frozen genetic engineering strain transformation
Detailed Description
The following examples were all carried out by a conventional experimental method, the experimental materials were commercially available, and the double plasmid coexpression L-TD, LDH and FDH gene engineering strains were constructed in the early stage from the subject group (patent publication No.: CN 109266595A).
Method for measuring content of (I) 2-aminobutyric acid
Sample pretreatment: centrifuging the transformation solution at 12000rpm for 10min, collecting supernatant, and preparing standard solution with alpha-ketobutyric acid or 2-aminobutyric acid as standard. Filtering the supernatant and the standard solution after appropriate dilution with 0.22 μm microporous membrane, and measuring 2-aminobutyric acid by high performance liquid chromatography.
Determination of 2-aminobutyric acid content: high performance liquid chromatography with ortho-phthalaldehyde (OPA) as derivatization reagent, ZO RBAX SB-C18 as chromatographic column, and 10mmol/L KH as mobile phase A2PO4(4mol/L KOH pH 5.3), mobile phase B acetonitrile: methanol: and (3) carrying out gradient elution on the phase A (5: 3:1 (pH 5.3 adjusted by glacial acetic acid), wherein the flow rate is 1mL/min, and the detection wavelength is 330, 460nm and the column temperature is 30 ℃.
(II) definition and detection method of enzyme activities of L-TD, LDH and FDH
And (3) detecting the enzymatic activity of threonine deaminase: 200. mu.L of appropriately diluted BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD bacterial solution was taken, 1800. mu.L of a substrate (substrate system: 50mmol/L of threonine dissolved in potassium dihydrogenphosphate-dipotassium hydrogenphosphate buffer solution of pH 7.5) was added, and the mixture was reacted in a thermostatic water bath at 37 ℃ for 15 minutes, followed by boiling to terminate the reaction. Samples were diluted 10-fold and threonine reduction was measured using HPLC-OPA pre-column derivatization. The enzyme activity unit U is defined as the amount of enzyme required for a 1. mu. mol reduction of threonine in 1 min.
And (3) detecting the activity of leucine dehydrogenase: 200. mu.L of appropriately diluted BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD bacterial solution was taken, and 1800. mu.L of substrate (substrate system: 30mg/L NAD was dissolved using 50mmol/L pH 8.0 monobasic sodium phosphate-dibasic sodium phosphate buffer solution +50 mmol/L2-ketobutyric acid, 40mmol/L ammonium formate), reacting in a thermostatic water bath at 37 ℃ for 15min, and then boiling to terminate the reaction. The sample was diluted 10-fold and the amount of 2-aminobutyric acid produced was measured by HPLC-OPA pre-column derivatization. The enzyme activity unit U is defined as the amount of enzyme required for 1. mu. mol increase of 2-aminobutyric acid within 1 min.
Detecting the activity of the formate dehydrogenase: 200. mu.L of appropriately diluted BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD bacterial solution was taken, and 1600. mu.L of substrate (substrate system: 0.167mmol/L ammonium formate dissolved in 50mmol/L pH 8.0 monobasic sodium phosphate-dibasic sodium phosphate buffer, 1.67mmol/L NAD+) The reaction was carried out at 37 ℃ and absorbance of NADH at 340nm was measured every 30 seconds by a microplate reader and plotted. Different concentrations are configuredAbsorbance of NADH standard solution (0-0.6mmol/L) was measured at 340nm, a standard curve was plotted, and a regression equation was fitted. The enzyme activity unit U is defined as the amount of enzyme required to produce 1. mu. mol NADH within 1 min.
Definition of 100% enzyme activity: and (3) detecting the enzyme activity when fresh wet cells are collected after fermentation is finished.
(III) culture Medium
The seed culture medium formula comprises: LB culture medium, yeast powder 5g/L, tryptone 10g/L, NaCl 10 g/L.
The fermentation medium formula comprises: 8g/L of glycerol, 8g/L of yeast powder, 10g/L of soybean peptone and K2HPO4·12H2O 6.0g/L,KH2PO4 10.0g/L。
Composition of the feed medium: glycerol 500g/L, MgSO4·7H2O 10g/L。
Example 1 Effect of protective agent addition on enzyme Activity
Inoculating BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD into a fermentation culture medium according to the inoculation amount of 5%, wherein the ventilation amount is 2.0vvm, the temperature is 37 ℃, the stirring speed is 500rpm, the fermentation is carried out for 5-6 h, when the dissolved oxygen suddenly rises, the dissolved oxygen-related feeding is started, the dissolved oxygen is controlled to be 30-40%, and the culture is carried out until the OD is OD600Reducing the temperature to 25 ℃ and adding 10g/L lactose to induce the expression of target proteins L-TD, LDH and FDH, and performing fermentation culture for 22-24 h and OD600At 70-75 ℃, ending fermentation, closing ventilation, reducing the stirring speed to 50rpm, and cooling the fermentation tank to 10-15 ℃.
And respectively adding 50mmol/L Cys and 10 mu mol/L PLP into the fermentation liquor, simultaneously adding 50mmol/L Cys and 10 mu mol/L PLP, uniformly mixing, centrifuging at the temperature of 4-15 ℃, centrifuging at 6000rpm, and collecting wet cells for 5 min. The wet cells are frozen at the temperature of minus 20 ℃, and are sampled at intervals of different days, and the detection of the change condition of the enzyme activity of the FDH is taken as an index because the FDH storage enzyme activity is unstable. The experimental results are shown in FIG. 1 (a-c): along with the prolonging of the freezing preservation time, the enzyme activities of L-TD, LDH and FDH are continuously reduced; when no protective agent is added, the enzyme activities of L-TD, LDH and FDH are reduced to 88.2%, 70.2% and 72.6% of the original enzyme activities, and the freezing enzyme activity stability is L-TD > FDH > LDH; when the three enzymes are stored for 30 days, and 50mmol/L Cys and 10 mu mol/L PLP are added simultaneously, the enzyme activities of the three enzymes are all maintained at more than 95.0 percent.
Example 2 Effect of different centrifugation methods on enzyme Activity
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD was fermented in the culture mode of example 1, 50mmol/L Cys and 10. mu. mol/L PLP were added to the fermentation broth, the centrifugation temperature was 4-25 ℃, the centrifugation speed was 4000-8000 rpm, and wet cells were collected for 5 min. Freezing wet cells at-20 ℃, freezing for 30 days to detect relative enzyme activities of L-TD, LDH and FDH, wherein experimental results are shown in table 1, and the influence of centrifugal rotating speed and time on the enzyme activity is respectively considered in experiment 1, experiment 2 and experiment 3 groups and experiment 2, experiment 4 and experiment 5 groups, when the centrifugal rotating speed is low, the time is short, the water content of the wet cells is high, the protein is damaged due to the formation of ice crystals in the freezing process, and after freezing for 30 days, only the L-TD enzyme activity with the best stability can be maintained at about 90%; 2. groups 6, 7 and 8 investigate the influence of different centrifugal temperatures on enzyme activity, when the centrifugal temperatures are 4 ℃ and 15 ℃, the enzyme activities of the three enzymes can be maintained to be more than 94.9 percent, when the centrifugal temperatures are increased to be 25 ℃ and 30 ℃, partial protein denaturation is inactivated by high temperature, and the enzyme activities of LDH and FDH are reduced to be less than 90 percent.
TABLE 1 Effect of different centrifugation methods on enzyme Activity
Figure BDA0002085434670000051
Example 3 Effect of repeated Freeze/thaw mode on enzyme Activity
A system for producing L-2-aminobutyric acid by converting L-threonine in a 5L fermentation tank: stirring at 400r/min and 37 deg.C, aerating at 3vvm, dissolving L-threonine in purified water at 80g/L and ammonium formate at 40g/L, and dissolving NAD in water+30mg/L of wet cells, 20g/L of wet cells, pH 8.0 controlled with 4mol/L NaOH solution, and conversion volume 2L.
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD were fermented in the same manner as in example 1, 50mmol/L Cys and 10. mu. mol/L PLP were added to the fermentation broth, the centrifugation temperature was 10 ℃, the centrifugation speed was set at 8000rpm, wet cells were collected for 5min, and the wet cells were frozen at-20 ℃ for 30 days and then used for transformation experiments. Thawing frozen wet cells, then freezing, namely freezing and thawing once, naturally thawing or stirring thalli by using a magnetic stirrer for thawing, and investigating the influence of repeated freezing and thawing modes on the transformation production of the L-2-aminobutyric acid by the wet cells, wherein the results are shown in Table 2, the thawed thalli in the experiment groups 1, 2 and 3 are directly used for transformation, the yield of the L-2-aminobutyric acid is 68.1g/L, and the yield of the freezing and thawing once and twice is respectively reduced to 63.2g/L and 56.9 g/L; experiments 1, 4, 5 and 6 investigate the influence of different stirring rates on enzyme activity, the thalli which are naturally thawed and are stirred and thawed at a substrate of 50rpm are used for a conversion experiment, the conversion rate of L-threonine is more than 98.0 percent, the stirring rotating speed is increased, and the conversion rate is obviously reduced; the cell membrane is incomplete due to freeze thawing or rapid stirring and thawing of the thalli, and the heterogeneously expressed intracellular enzyme has no stable protection system, so that the enzyme activity is reduced, and the conversion period is prolonged.
TABLE 2 Effect of repeated freezing and thawing mode on enzyme Activity
Figure BDA0002085434670000061
EXAMPLE 4 production of L-2-aminobutyric acid by transformation of frozen genetically engineered Strain
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD were fermented in the same manner as in example 1, 50mmol/L Cys and 10. mu. mol/L PLP were added to the fermentation broth, 8000rpm was applied, and the mixture was centrifuged at 15 ℃ for 5min to collect wet cells. The wet cells are frozen at the temperature of minus 20 ℃, the enzyme activities of L-TD, LDH and FDH are detected after the wet cells are frozen for 30, 60 and 90 days, the wet cells are naturally unfrozen and then put into a transformation system for transformation experiment, the transformation mode is the same as that of example 3, and the experimental results are shown in figure 2: the wet thalli is preserved according to the method of the invention, and is frozen for 60 days, and the enzyme activity of three enzymes in the genetic engineering strain can reach more than 90 percent of that of the fresh thalli; freezing for 60 days, wherein the yield of L-2-aminobutyric acid used for converting and producing the target product is 67.0g/L, and the conversion rate of L-threonine is 96.8%; after the mixture is frozen for 90 days, the relative enzyme activities of L-TD, LDH and FDH are respectively reduced to 93.2 percent, 85.3 percent and 89.3 percent, and the yield of the L-2-aminobutyric acid only can reach 62.1 g/L.
Comparative example 1
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD were fermented in the same manner as in example 1, 50 mmol/L. beta. -mercaptoethanol and 10. mu. mol/L PLP were added to the fermentation broth, the centrifugation temperature was 10 ℃ and the centrifugation speed was set at 8000rpm, and wet cells were collected for 5 min. After 30 days of storage, the relative enzyme activities of L-TD, LDH and FDH were 84.8%, 81.9% and 80.8%, respectively.
Comparative example 2
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD were fermented in the same manner as in example 1, 50mmol/L glutathione and 10. mu. mol/L PLP were added to the fermentation broth, the centrifugation temperature was 10 ℃ and the centrifugation speed was set at 8000rpm, and wet cells were collected for 5 min. After 30 days of storage, the relative enzyme activities of L-TD, LDH and FDH were 85.6%, 82.3% and 80.3%, respectively.
Comparative example 3
BL21/pRSFDuet-BtLeuDH + pETduet-CbFDH-EcTD were fermented in the same manner as in example 1, 50mmol/L dithiothreitol and 10. mu. mol/L PLP were added to the fermentation broth, the centrifugation temperature was 10 ℃ and the centrifugation speed was set at 8000rpm, and wet cells were collected for 5 min. After 30 days of storage, the relative enzyme activities of L-TD, LDH and FDH were 82.6%, 83.7% and 87.6%, respectively.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of south of the Yangtze river
<120> method for collecting and preserving wet cells of genetically engineered bacteria
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 1545
<212> DNA
<213> Artificial Synthesis
<400> 1
atggctgact cgcaacccct gtccggtgct ccggaaggtg ccgaatattt aagagcagtg 60
ctgcgcgcgc cggtttacga ggcggcgcag gttacgccgc tacaaaaaat ggaaaaactg 120
tcgtcgcgtc ttgataacgt cattctggtg aagcgcgaag atcgccagcc agtgcacagc 180
tttaagctgc gcggcgcata cgccatgatg gcgggcctga cggaagaaca gaaagcgcac 240
ggcgtgatca ctgcttctgc gggtaaccac gcgcagggcg tcgcgttttc ttctgcgcgg 300
ttaggcgtga aggccctgat cgttatgcca accgccaccg ccgacatcaa agtcgacgcg 360
gtgcgcggct tcggcggcga agtgctgctc cacggcgcga actttgatga agcgaaagcc 420
aaagcgatcg aactgtcaca gcagcagggg ttcacctggg tgccgccgtt cgaccatccg 480
atggtgattg ccgggcaagg cacgctggcg ctggaactgc tccagcagga cgcccatctc 540
gaccgcgtat ttgtgccagt cggcggcggc ggtctggctg ctggcgtggc ggtgctgatc 600
aaacaactga tgccgcaaat caaagtgatc gccgtagaag cggaagactc cgcctgcctg 660
aaagcagcgc tggatgcggg tcatccggtt gatctgccgc gcgtagggct atttgctgaa 720
ggcgtagcgg taaaacgcat cggtgacgaa accttccgtt tatgccagga gtatctcgac 780
gacatcatca ccgtcgatag cgatgcgatc tgtgcggcga tgaaggattt attcgaagat 840
gtgcgcgcgg tggcggaacc ctctggcgcg ctggcgctgg cgggaatgaa aaaatatatc 900
gccctgcaca acattcgcgg cgaacggctg gcgcatattc tttccggtgc caacgtgaac 960
ttccacggcc tgcgctacgt ctcagaacgc tgcgaactgg gcgaacagcg tgaagcgttg 1020
ttggcggtga ccattccgga agaaaaaggc agcttcctca aattctgcca actgcttggc 1080
gggcgttcgg tcaccgagtt caactaccgt tttgccgatg ccaaaaacgc ctgcatcttt 1140
gtcggtgtgc gcctgagccg cggcctcgaa gagcgcaaag aaattttgca gatgctcaac 1200
gacggcggct acagcgtggt tgatctctcc gacgacgaaa tggcgaagct acacgtgcgc 1260
tatatggtcg gcggacgtcc atcgcatccg ttgcaggaac gcctctacag cttcgaattc 1320
ccggaatcac cgggcgcgct gctgcgcttc ctcaacacgc tgggtacgta ctggaacatt 1380
tctttgttcc actatcgcag ccatggcacc gactacgggc gcgtactggc ggcgttcgaa 1440
cttggcgacc atgaaccgga tttcgaaacc cggctgaatg agctgggcta cgattgccac 1500
gacgaaacca ataacccggc gttcaggttc tttttggcgg gttaa 1545
<210> 2
<211> 1101
<212> DNA
<213> Artificial Synthesis
<400> 2
atgacattag aaatcttcga atacttagaa aaatatgatt atgagcaagt agtattttgt 60
caagataaag aatctggttt aaaagcaatt attgcaattc atgatacaac acttggaccg 120
gctcttggtg gaacaagaat gtggacatat gattctgaag aagcggcgat tgaagatgca 180
ttgcgtcttg caaaagggat gacatataaa aacgcagcag ctggtttaaa cttaggtggt 240
gcgaaaacag taattatcgg tgatcctcgt aaagataaga gcgaagcaat gttccgtgca 300
ctaggacgtt atatccaagg actaaacgga cgttacatta cagctgaaga tgttggtaca 360
acagtagatg atatggatat tatccatgaa gaaactgact ttgtaacagg tatctcacca 420
tcattcggtt cttctggtaa cccatctcca gtaactgcat acggtgttta ccgtggtatg 480
aaagcagctg caaaagaagc tttcggtact gacaatttag aaggaaaagt aattgctgtt 540
caaggcgttg gtaacgtagc atatcaccta tgcaaacatt tacacgctga aggagcaaaa 600
ttaatcgtta cagatattaa taaagaagct gtacaacgtg ctgtagaaga attcggtgca 660
tcagcagttg aaccaaatga aatttatggt gttgaatgcg atatttacgc accatgtgca 720
ttaggcgcaa cagttaatga tgaaactatt ccacaactta aagcaaaagt aatcgcaggt 780
tctgcaaata accaattaaa agaaaatcgt cacggtgaca tcattcatga aatgggtatt 840
gtatacgcac cagattatgt aattaatgca ggtggcgtaa ttaacgtagc agacgaatta 900
tatggataca atagagaacg tgcactaaaa cgtgttgagt ctatttatga cacaattgca 960
aaagtaatcg aaatttcaaa acgcgatggc atagcaactt atgtagcggc agatcgtcta 1020
gctgaagagc gcattgcaag cttgaaaaat tctcgtagca cttacttacg caacggtcac 1080
gatattatta gccgtcgcta a 1101
<210> 3
<211> 1098
<212> DNA
<213> Artificial Synthesis
<400> 3
atgaaaattg tgctggtgct gtatgatgcg ggcaaacatg cggcggatga agaaaaactg 60
tatggctgca ccgaaaataa actgggcatt gcgaactggc tgaaagatca gggccatgaa 120
ctgattacca cctctgataa agaaggcggc aacagcgttc tggatcagca tattccggat 180
gcggatatta ttattaccac cccgtttcat ccggcgtata tcaccaaaga acgcatcgat 240
aaagcgaaaa aactgaaact ggtggtggtg gcgggcgtgg gcagcgatca tattgatctg 300
gattatatca accagaccgg taaaaaaatt agcgtgctgg aagtgaccgg cagcaacgtg 360
gtgagcgtgg cggaacatgt ggtgatgacc atgctggtgc tggtgcgtaa ctttgtgccg 420
gcgcatgaac aaattattaa ccacgattgg gaagtggcgg cgattgcgaa agatgcgtat 480
gatatcgaag gcaaaaccat tgcgaccatt ggcgcgggtc gtattggcta tcgtgtgctg 540
gaacgtctgg tgccgtttaa tccgaaagaa ctgctgtatt atgattatca ggcgctgccg 600
aaagatgcgg aagaaaaagt gggtgcgcgt cgtgtggaaa acattgaaga actggtggcg 660
caggcggata ttgtgaccgt gaacgcgccg ctgcatgcgg gcaccaaagg cctgatcaac 720
aaagagctgc tgtctaagtt taaaaaaggc gcgtggctgg tgaataccgc gcgtggcgcg 780
atttgcgtgg ccgaagatgt tgcggcggcg ctggaaagcg gtcagctgcg tggctatggc 840
ggtgatgtgt ggtttccgca gccggcgccg aaagatcatc cgtggcgtga tatgcgtaac 900
aaatatggcg cgggtaacgc catgaccccg cattatagcg gcaccaccct ggatgcgcag 960
acccgttatg cgcagggcac caaaaacatt ctggaaagct ttttcaccgg caaatttgat 1020
tatcgtccgc aggacattat tctgctgaac ggcgaatatg tgaccaaagc gtatggcaaa 1080
cacgataaaa aataataa 1098
<210> 4
<211> 514
<212> PRT
<213> Artificial Synthesis
<400> 4
Met Ala Asp Ser Gln Pro Leu Ser Gly Ala Pro Glu Gly Ala Glu Tyr
1 5 10 15
Leu Arg Ala Val Leu Arg Ala Pro Val Tyr Glu Ala Ala Gln Val Thr
20 25 30
Pro Leu Gln Lys Met Glu Lys Leu Ser Ser Arg Leu Asp Asn Val Ile
35 40 45
Leu Val Lys Arg Glu Asp Arg Gln Pro Val His Ser Phe Lys Leu Arg
50 55 60
Gly Ala Tyr Ala Met Met Ala Gly Leu Thr Glu Glu Gln Lys Ala His
65 70 75 80
Gly Val Ile Thr Ala Ser Ala Gly Asn His Ala Gln Gly Val Ala Phe
85 90 95
Ser Ser Ala Arg Leu Gly Val Lys Ala Leu Ile Val Met Pro Thr Ala
100 105 110
Thr Ala Asp Ile Lys Val Asp Ala Val Arg Gly Phe Gly Gly Glu Val
115 120 125
Leu Leu His Gly Ala Asn Phe Asp Glu Ala Lys Ala Lys Ala Ile Glu
130 135 140
Leu Ser Gln Gln Gln Gly Phe Thr Trp Val Pro Pro Phe Asp His Pro
145 150 155 160
Met Val Ile Ala Gly Gln Gly Thr Leu Ala Leu Glu Leu Leu Gln Gln
165 170 175
Asp Ala His Leu Asp Arg Val Phe Val Pro Val Gly Gly Gly Gly Leu
180 185 190
Val Ala Gly Val Ala Val Leu Ile Lys Gln Leu Met Pro Gln Ile Lys
195 200 205
Val Ile Ala Val Glu Ala Glu Asp Ser Ala Cys Leu Lys Ala Ala Leu
210 215 220
Asp Ala Gly His Pro Val Asp Leu Pro Arg Val Gly Leu Phe Ala Glu
225 230 235 240
Gly Val Ala Val Lys Arg Ile Gly Asp Glu Thr Phe Arg Leu Cys Gln
245 250 255
Glu Tyr Leu Asp Asp Ile Ile Thr Val Asp Ser Asp Ala Ile Cys Ala
260 265 270
Ala Met Lys Asp Leu Phe Glu Asp Val Arg Ala Val Ala Glu Pro Ser
275 280 285
Gly Ala Leu Ala Leu Ala Gly Met Lys Lys Tyr Ile Ala Leu His Asn
290 295 300
Ile Arg Gly Glu Arg Leu Ala His Ile Leu Ser Gly Ala Asn Val Asn
305 310 315 320
Phe His Gly Leu Arg Tyr Val Ser Glu Arg Cys Glu Leu Gly Glu Gln
325 330 335
Arg Glu Ala Leu Leu Ala Val Thr Ile Pro Glu Glu Lys Gly Ser Phe
340 345 350
Leu Lys Phe Cys Gln Leu Leu Gly Gly Arg Ser Val Thr Glu Phe Asn
355 360 365
Tyr Arg Phe Ala Asp Ala Lys Asn Ala Cys Ile Phe Val Gly Val Arg
370 375 380
Leu Ser Arg Gly Leu Glu Glu Arg Lys Glu Ile Leu Gln Met Leu Asn
385 390 395 400
Asp Gly Gly Tyr Ser Val Val Asp Leu Ser Asp Asp Glu Met Ala Lys
405 410 415
Leu His Val Arg Tyr Met Val Gly Gly Arg Pro Ser His Pro Leu Gln
420 425 430
Glu Arg Leu Tyr Ser Phe Glu Phe Pro Glu Ser Pro Gly Ala Leu Leu
435 440 445
Arg Phe Leu Asn Thr Leu Gly Thr Tyr Trp Asn Ile Ser Leu Phe His
450 455 460
Tyr Arg Ser His Gly Thr Asp Tyr Gly Arg Val Leu Ala Ala Phe Glu
465 470 475 480
Leu Gly Asp His Glu Pro Asp Phe Glu Thr Arg Leu Asn Glu Leu Gly
485 490 495
Tyr Asp Cys His Asp Glu Thr Asn Asn Pro Ala Phe Arg Phe Phe Leu
500 505 510
Ala Gly
<210> 5
<211> 366
<212> PRT
<213> Artificial Synthesis
<400> 5
Met Thr Leu Glu Ile Phe Glu Tyr Leu Glu Lys Tyr Asp Tyr Glu Gln
1 5 10 15
Val Val Phe Cys Gln Asp Lys Glu Ser Gly Leu Lys Ala Ile Ile Ala
20 25 30
Ile His Asp Thr Thr Leu Gly Pro Ala Leu Gly Gly Thr Arg Met Trp
35 40 45
Thr Tyr Asp Ser Glu Glu Ala Ala Ile Glu Asp Ala Leu Arg Leu Ala
50 55 60
Lys Gly Met Thr Tyr Lys Asn Ala Ala Ala Gly Leu Asn Leu Gly Gly
65 70 75 80
Ala Lys Thr Val Ile Ile Gly Asp Pro Arg Lys Asp Lys Ser Glu Ala
85 90 95
Met Phe Arg Ala Leu Gly Arg Tyr Ile Gln Gly Leu Asn Gly Arg Tyr
100 105 110
Ile Thr Ala Glu Asp Val Gly Thr Thr Val Asp Asp Met Asp Ile Ile
115 120 125
His Glu Glu Thr Asp Phe Val Thr Gly Ile Ser Pro Ser Phe Gly Ser
130 135 140
Ser Gly Asn Pro Ser Pro Val Thr Ala Tyr Gly Val Tyr Arg Gly Met
145 150 155 160
Lys Ala Ala Ala Lys Glu Ala Phe Gly Thr Asp Asn Leu Glu Gly Lys
165 170 175
Val Ile Ala Val Gln Gly Val Gly Asn Val Ala Tyr His Leu Cys Lys
180 185 190
His Leu His Ala Glu Gly Ala Lys Leu Ile Val Thr Asp Ile Asn Lys
195 200 205
Glu Ala Val Gln Arg Ala Val Glu Glu Phe Gly Ala Ser Ala Val Glu
210 215 220
Pro Asn Glu Ile Tyr Gly Val Glu Cys Asp Ile Tyr Ala Pro Cys Ala
225 230 235 240
Leu Gly Ala Thr Val Asn Asp Glu Thr Ile Pro Gln Leu Lys Ala Lys
245 250 255
Val Ile Ala Gly Ser Ala Asn Asn Gln Leu Lys Glu Asn Arg His Gly
260 265 270
Asp Ile Ile His Glu Met Gly Ile Val Tyr Ala Pro Asp Tyr Val Ile
275 280 285
Asn Ala Gly Gly Val Ile Asn Val Ala Asp Glu Leu Tyr Gly Tyr Asn
290 295 300
Arg Glu Arg Ala Leu Lys Arg Val Glu Ser Ile Tyr Asp Thr Ile Ala
305 310 315 320
Lys Val Ile Glu Ile Ser Lys Arg Asp Gly Ile Ala Thr Tyr Val Ala
325 330 335
Ala Asp Arg Leu Ala Glu Glu Arg Ile Ala Ser Leu Lys Asn Ser Arg
340 345 350
Ser Thr Tyr Leu Arg Asn Gly His Asp Ile Ile Ser Arg Arg
355 360 365
<210> 6
<211> 364
<212> PRT
<213> Artificial Synthesis
<400> 6
Met Lys Ile Val Leu Val Leu Tyr Asp Ala Gly Lys His Ala Ala Asp
1 5 10 15
Glu Glu Lys Leu Tyr Gly Cys Thr Glu Asn Lys Leu Gly Ile Ala Asn
20 25 30
Trp Leu Lys Asp Gln Gly His Glu Leu Ile Thr Thr Ser Asp Lys Glu
35 40 45
Gly Gly Asn Ser Val Leu Asp Gln His Ile Pro Asp Ala Asp Ile Ile
50 55 60
Ile Thr Thr Pro Phe His Pro Ala Tyr Ile Thr Lys Glu Arg Ile Asp
65 70 75 80
Lys Ala Lys Lys Leu Lys Leu Val Val Val Ala Gly Val Gly Ser Asp
85 90 95
His Ile Asp Leu Asp Tyr Ile Asn Gln Thr Gly Lys Lys Ile Ser Val
100 105 110
Leu Glu Val Thr Gly Ser Asn Val Val Ser Val Ala Glu His Val Val
115 120 125
Met Thr Met Leu Val Leu Val Arg Asn Phe Val Pro Ala His Glu Gln
130 135 140
Ile Ile Asn His Asp Trp Glu Val Ala Ala Ile Ala Lys Asp Ala Tyr
145 150 155 160
Asp Ile Glu Gly Lys Thr Ile Ala Thr Ile Gly Ala Gly Arg Ile Gly
165 170 175
Tyr Arg Val Leu Glu Arg Leu Val Pro Phe Asn Pro Lys Glu Leu Leu
180 185 190
Tyr Tyr Asp Tyr Gln Ala Leu Pro Lys Asp Ala Glu Glu Lys Val Gly
195 200 205
Ala Arg Arg Val Glu Asn Ile Glu Glu Leu Val Ala Gln Ala Asp Ile
210 215 220
Val Thr Val Asn Ala Pro Leu His Ala Gly Thr Lys Gly Leu Ile Asn
225 230 235 240
Lys Glu Leu Leu Ser Lys Phe Lys Lys Gly Ala Trp Leu Val Asn Thr
245 250 255
Ala Arg Gly Ala Ile Cys Val Ala Glu Asp Val Ala Ala Ala Leu Glu
260 265 270
Ser Gly Gln Leu Arg Gly Tyr Gly Gly Asp Val Trp Phe Pro Gln Pro
275 280 285
Ala Pro Lys Asp His Pro Trp Arg Asp Met Arg Asn Lys Tyr Gly Ala
290 295 300
Gly Asn Ala Met Thr Pro His Tyr Ser Gly Thr Thr Leu Asp Ala Gln
305 310 315 320
Thr Arg Tyr Ala Gln Gly Thr Lys Asn Ile Leu Glu Ser Phe Phe Thr
325 330 335
Gly Lys Phe Asp Tyr Arg Pro Gln Asp Ile Ile Leu Leu Asn Gly Glu
340 345 350
Tyr Val Thr Lys Ala Tyr Gly Lys His Asp Lys Lys
355 360

Claims (8)

1. A method for collecting and storing wet cells of a genetic engineering strain is characterized in that fermentation liquor of the genetic engineering strain is cooled to 4-15 ℃, 50-100 mmol/L cysteine and 5-20 mu mol/L coenzyme pyridoxal phosphate are added, the mixture is uniformly mixed and then centrifuged at 6000-8000 rpm for 5-10 min to obtain wet cells, and the wet cells are frozen and stored at-10-20 ℃; the genetic engineering strain takes escherichia coli as a host to co-express threonine deaminase, formate dehydrogenase and leucine dehydrogenase; the centrifugation temperature is 4-15 ℃.
2. The collection and preservation method according to claim 1, wherein the moisture content of the collected wet cell bacterial sludge is 75% to 80%.
3. The collection and storage method according to claim 1, wherein the amino acid sequence of threonine deaminase is represented by SEQ ID No.4, the amino acid sequence of leucine dehydrogenase is represented by SEQ ID No.5, and the amino acid sequence of formate dehydrogenase is represented by SEQ ID No. 6.
4. The collection and storage method according to claim 1, wherein the genetically engineered strain expresses threonine deaminase and formate dehydrogenase using pETDuet-1 plasmid and leucine dehydrogenase using pRSFDuet-1 plasmid.
5. The collection and storage method according to claim 1, wherein the Escherichia coli is Escherichia coli (Escherichia coli) BL 21.
6. Use of a process according to any one of claims 1 to 5 for the production of L-2-aminobutyric acid.
7. The application of claim 6, wherein the genetically engineered strain is prepared by co-expressing three enzymes of threonine deaminase, formate dehydrogenase and leucine dehydrogenase with Escherichia coli as a host, cooling fermentation liquor of the genetically engineered strain to 4-15 ℃, adding 50-100 mmol/L cysteine and 5-20 μmol/L coenzyme pyridoxal phosphate, mixing uniformly, centrifuging at 6000-8000 rpm for 5-10 min to obtain wet cells, and producing the L-2-aminobutyric acid by taking the obtained wet cells of the genetically engineered strain as a whole-cell catalyst with L-threonine as a substrate.
8. The use of claim 7, wherein when the genetically engineered strain is used in transformation experiments, 3.5-4.5 times of deionized water with a volume of 15-25 ℃ is added, and the strain is naturally thawed or is thawed by stirring at a low speed of 25-50 rpm.
CN201910486085.1A 2019-06-05 2019-06-05 Method for collecting and preserving wet cells of genetically engineered bacteria Active CN110229773B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910486085.1A CN110229773B (en) 2019-06-05 2019-06-05 Method for collecting and preserving wet cells of genetically engineered bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910486085.1A CN110229773B (en) 2019-06-05 2019-06-05 Method for collecting and preserving wet cells of genetically engineered bacteria

Publications (2)

Publication Number Publication Date
CN110229773A CN110229773A (en) 2019-09-13
CN110229773B true CN110229773B (en) 2021-08-24

Family

ID=67858568

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910486085.1A Active CN110229773B (en) 2019-06-05 2019-06-05 Method for collecting and preserving wet cells of genetically engineered bacteria

Country Status (1)

Country Link
CN (1) CN110229773B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109266595A (en) * 2018-09-25 2019-01-25 江南大学 A kind of building and application of the recombinant bacterium of conversion L-threonine production C4H9NO2

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109266595A (en) * 2018-09-25 2019-01-25 江南大学 A kind of building and application of the recombinant bacterium of conversion L-threonine production C4H9NO2

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cloning, expression, purification, and characterization of biosynthetic threonine deaminase from Escherichia coli;E Eisenstein;《J Biol Chem》;19910325;第266卷(第9期);第5801页右栏第一段 *
用于合成L-2-氨基丁酸基因工程菌的构建;郭红颜等;《中国医药工业杂志》;20151231;第46卷(第10期);参见全文 *

Also Published As

Publication number Publication date
CN110229773A (en) 2019-09-13

Similar Documents

Publication Publication Date Title
CN106929521B (en) Aldehyde ketone reductase gene recombination co-expression vector, engineering bacterium and application thereof
JPH09505469A (en) Recombinant yeast for efficient fermentation of glucose and xylose
CN110564788B (en) Method for producing ephedrine by using imine reductase
CN112831488B (en) Glutamic acid decarboxylase and gamma-aminobutyric acid high-yield strain
CN109735553A (en) A kind of preparation method of anti-AIDS drug atazanavir intermediate
CN111019982B (en) Method for preparing L-glufosinate-ammonium by using hydroxy acid dehydrogenase
CN118291410A (en) Alcohol dehydrogenase mutant and application thereof in preparation of high-concentration (S) -vitronectin
CN113817693B (en) Short-chain carbonyl reductase PpYSDR mutant, encoding gene, recombinant expression vector, genetic engineering bacterium and application
CN113430181B (en) Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof
CN109706189B (en) Preparation method of D-chiro-inositol
CN111926002B (en) TrpE mutant and application thereof in gene engineering bacteria for producing L-tryptophan
CN110229773B (en) Method for collecting and preserving wet cells of genetically engineered bacteria
CN108192853B (en) Method for promoting microbial cells to transport glucose, xylose and arabinose and application of method in fermentation of bio-based products
CN109943542A (en) A kind of alcohol dehydrogenase for the production of atazanavir intermediate
CN113151378B (en) Method for preparing nucleoside, nicotinic acid adenine dinucleotide and nicotinic acid mononucleotide of nicotinic acid or derivative thereof, enzyme composition and application
CN111500614A (en) Plasmid for efficiently catalyzing L-threonine to synthesize 2,5-DMP (dimethyl formamide) and construction and application thereof
CN111718950A (en) Method for improving fermentation production of pyruvic acid by engineering bacteria by knocking out pyruvic acid transport protein gene
CN113583983A (en) Fusion protein or variant thereof and application thereof in preparation of calcifediol
CN114395542B (en) Sucrose phosphorylase and application thereof
CN114250207B (en) High-activity sucrose phosphorylase and application thereof
CN110004121A (en) A kind of cholesterol oxidase and its application
CN114457055B (en) Carboxylesterase, coding gene, genetically engineered bacterium and application thereof
CN113025546B (en) Method for producing tyrosol by converting L-tyrosine through multienzyme cascade
CN118291557B (en) Coenzyme A transferase, screening method thereof and application thereof in P34HB synthesis
CN114774398B (en) High-density fermentation method of recombinant EK enzyme engineering bacteria

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant